
FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
Medicare beneficiary use of telehealth services reached nearly 9 million as COVID-19 shut down on-site visits. Will the options be permanent?






